Answers are grounded in this paper and cite their sources.
Myelodysplastic syndrome (MDS) encompasses a heterogeneous group of disorders. MDS and pancytopaenia are possible side effects of disease‐modifying anti‐rheumatic drug (DMARD) therapy [1], [2]. We ...
No takes yet. Share an insight, caveat, or question.
Thonhofer et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: